In Vitro to In Vivo Extrapolation of Toxicant Effects on Ovarian Function
Project Number1R01ES034690-01A1
Former Number1R01ES034690-01
Contact PI/Project LeaderCRAIG, ZELIEANN RIVERA
Awardee OrganizationUNIVERSITY OF ARIZONA
Description
Abstract Text
PROJECT SUMMARY
Approximately 7.5 million American women are unable to become pregnant or carry a baby to term (impaired
fecundity). The ovary is considered a critical target organ in infertility cases based on the large number of
women seeking infertility treatment who are unable to release a viable egg from their ovaries. Folliculogenesis
is the process through which ovarian follicles, the functional units of the ovary, develop into a form capable of
sustaining hormone production and ovulating a healthy egg for fertilization. Any environmental exposure that
causes damage to the ovarian follicle has the potential to impair fecundity in women. Most of what is known
about toxicity to ovarian follicles has been uncovered in laboratory rodents, but there is little available data on
toxicant exposure and related mechanistic toxicology studies in the nonhuman primate, the closest laboratory
animal model to humans. There is, therefore, a critical need to develop alternative approaches and tools that
synergize the accessibility and versatility of laboratory rodents with the physiological relevance of the
nonhuman primate to deliver high quality ovarian follicle toxicity data. To meet this need, this proposal will
support the formation of a virtual research consortium with expertise in mouse and nonhuman primate ovarian
biology, toxicology and computational modeling. The proposed consortium will generate lab-based data on the
physiological and toxicant-induced behavior of ovarian follicles in both species, using phthalate as a model
toxicant, to create computational models capable of effectively predicting ovarian follicle responses to chemical
insults in nonhuman primates. The experimental measures captured in the in vitro and in vivo model will be
specifically chosen to align with the needs of the modelers. To achieve this goal, the proposed consortium will
complete three specific aims. Specifically, the ovarian biology/toxicology team will quantify the physiological
and toxicant-induced behavior of computationally useful markers of in vivo and in vitro folliculogenesis in mice
(Aim 1) and nonhuman primates (Aim 2), while the computational modeling team will construct in silico models
that match the physiological behavior of folliculogenesis in each species and predict follicular responses to
phthalate insults in both species. Our virtual consortium includes researchers from five institutions and will
create a transdisciplinary group that includes both experimental and computational expertise. The tight
coupling of these two domains will provide the needed communication pathways to develop translational
models for IVIVE as well as cross-species extrapolations in reproductive toxicology.
Public Health Relevance Statement
PROJECT NARRATIVE
This proposal supports the creation of a virtual consortium that will use translational and transdisciplinary
disciplinary approaches to provide the research community with an innovative computationally-based method
to predict adverse effects of phthalates on ovarian function in women. This work will benefit human
reproductive health by enhancing the screening of chemicals that could harm ovarian function in women. The
transdisciplinary and translational environment created by this consortium will also provide unique cross-
disciplinary training opportunities to trainees in the five institutions involved.
National Institute of Environmental Health Sciences
CFDA Code
113
DUNS Number
806345617
UEI
ED44Y3W6P7B9
Project Start Date
01-February-2024
Project End Date
31-January-2027
Budget Start Date
01-February-2024
Budget End Date
31-January-2025
Project Funding Information for 2024
Total Funding
$744,972
Direct Costs
$627,487
Indirect Costs
$117,485
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Environmental Health Sciences
$744,972
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1R01ES034690-01A1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R01ES034690-01A1
Patents
No Patents information available for 1R01ES034690-01A1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R01ES034690-01A1
Clinical Studies
No Clinical Studies information available for 1R01ES034690-01A1
News and More
Related News Releases
No news release information available for 1R01ES034690-01A1
History
No Historical information available for 1R01ES034690-01A1
Similar Projects
No Similar Projects information available for 1R01ES034690-01A1